U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06819774) titled 'Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria' on Feb. 06.
Brief Summary: The objective of this study was to evaluate the efficacy and safety of cetirizine hydrochloride injection in the treatment of acute urticaria.The participants were randomized to receive cetirizine hydrochloride or diphenhydramine hydrochloride.
Study Start Date: April 22, 2024
Study Type: INTERVENTIONAL
Condition:
Acute Urticaria
Intervention:
DRUG: Cetirizine Hydrochloride Injection
The subjects received a single dose of 1-2 ml of the injection of cetirizine hydrochloride (administered by intravenous pus...